Cargando…

Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy

In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, Steffi, Stachs, Angrit, Kühn, Thorsten, de Boniface, Jana, Banys-Paluchowski, Maggie, Reimer, Toralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494517/
https://www.ncbi.nlm.nih.gov/pubmed/34629491
http://dx.doi.org/10.1055/a-1471-4234
_version_ 1784579327319343104
author Hartmann, Steffi
Stachs, Angrit
Kühn, Thorsten
de Boniface, Jana
Banys-Paluchowski, Maggie
Reimer, Toralf
author_facet Hartmann, Steffi
Stachs, Angrit
Kühn, Thorsten
de Boniface, Jana
Banys-Paluchowski, Maggie
Reimer, Toralf
author_sort Hartmann, Steffi
collection PubMed
description In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally as an alternative to complete axillary lymph node dissection. Tattooing of the suspicious lymph nodes with a highly purified carbon suspension is currently being investigated in clinical studies. Compared with other techniques, the advantages of this method are the high rate of intraoperative lymph node detection, avoidance of an immediately preoperative localisation procedure and the low costs. The practical aspects of lymph node tattooing and the current data regarding this method will be described.
format Online
Article
Text
id pubmed-8494517
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-84945172021-10-07 Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy Hartmann, Steffi Stachs, Angrit Kühn, Thorsten de Boniface, Jana Banys-Paluchowski, Maggie Reimer, Toralf Geburtshilfe Frauenheilkd In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally as an alternative to complete axillary lymph node dissection. Tattooing of the suspicious lymph nodes with a highly purified carbon suspension is currently being investigated in clinical studies. Compared with other techniques, the advantages of this method are the high rate of intraoperative lymph node detection, avoidance of an immediately preoperative localisation procedure and the low costs. The practical aspects of lymph node tattooing and the current data regarding this method will be described. Georg Thieme Verlag KG 2021-10 2021-10-06 /pmc/articles/PMC8494517/ /pubmed/34629491 http://dx.doi.org/10.1055/a-1471-4234 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Hartmann, Steffi
Stachs, Angrit
Kühn, Thorsten
de Boniface, Jana
Banys-Paluchowski, Maggie
Reimer, Toralf
Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title_full Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title_fullStr Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title_full_unstemmed Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title_short Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
title_sort targeted removal of axillary lymph nodes after carbon marking in patients with breast cancer treated with primary chemotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494517/
https://www.ncbi.nlm.nih.gov/pubmed/34629491
http://dx.doi.org/10.1055/a-1471-4234
work_keys_str_mv AT hartmannsteffi targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy
AT stachsangrit targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy
AT kuhnthorsten targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy
AT debonifacejana targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy
AT banyspaluchowskimaggie targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy
AT reimertoralf targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy